Related Experiment Videos
Modulation of P-glycoprotein expression in hyperthyroid rat tissues.
Naoki Nishio1, Toshiya Katsura, Kayoko Ashida
1Department of Pharmacy, Kyoto University Hospital, Kyoto 606-8507, Japan.
Summary
Thyroid hormone significantly impacts drug transporter P-glycoprotein (Pgp) expression, particularly in the kidney and liver. This study reveals tissue-specific effects of hyperthyroidism on Pgp and its mRNA levels.
Area of Science:
- Pharmacology
- Endocrinology
- Molecular Biology
Background:
- P-glycoprotein (Pgp) is crucial for drug absorption and disposition.
- Altered Pgp expression contributes to drug pharmacokinetic variability.
- Thyroid disorders can affect drug pharmacokinetics.
Purpose of the Study:
- To investigate the effect of hyperthyroidism on P-glycoprotein (Pgp) and mdr1a/1b mRNA expression.
- To determine tissue-specific alterations in Pgp expression in response to thyroid hormone.
Main Methods:
- Western blot analysis to quantify Pgp protein levels.
- Analysis of mdr1a/1b mRNA expression in kidney, liver, jejunum, and ileum.
- Comparison between euthyroid and hyperthyroid rat models.
Main Results:
- Pgp protein expression was significantly elevated in the kidney and liver of hyperthyroid rats.
- mdr1a/1b mRNA levels increased notably in the kidney but not in the liver or intestines.
- Jejunum and ileum showed only a slight increase in Pgp protein levels.
Conclusions:
- Thyroid hormone induces P-glycoprotein expression in a tissue-selective manner.
- The modulation of mdr1a/1b mRNA expression by hyperthyroidism differs across tissues.
- These findings highlight the complex interplay between thyroid status and drug transport mechanisms.